Towards Reduction or Substitution of Cytotoxic DMSO in Biobanking of Functional Bioengineered Megakaryocytes

Donor platelet transfusion is currently the only efficient treatment of life-threatening thrombocytopenia, but it is highly challenged by immunological, quality, and contamination issues, as well as short shelf life of the donor material. Ex vivo produced megakaryocytes and platelets represent a pro...

Full description

Bibliographic Details
Main Authors: Denys Pogozhykh, Dorothee Eicke, Oleksandr Gryshkov, Willem F. Wolkers, Kai Schulze, Carlos A. Guzmán, Rainer Blasczyk, Constança Figueiredo
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/20/7654